参考文献/References:
[1] Doran AC . Inflammation resolution:implications for atherosclerosis[J]. Circ Res,2022,130 (1):130-148.
[2] Nayor M,Brown KJ,Vasan RS. The molecular basis of predicting atherosclerotic cardiovascular disease risk[J]. Circ Res,2021,128 (2):287-303.
[3] O’Rourke SA,Neto NGB,Devilly E,et al. Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages[J]. Atherosclerosis,2022,352:35-45.
[4] Castellani CA,Longchamps RJ,Sumpter JA,et al. Mitochondrial DNA copy number can influence mortality and cardiovascular disease via methylation of nuclear DNA CpGs[J]. Genome Med,2020,12 (1):84.
[5] Ashar FN,Zhang Y,Longchamps RJ,et al. Association of mitochondrial DNA copy number with cardiovascular disease[J]. JAMA Cardiol,2017,2 (11):1247-1255.
[6] He L,Zhang CL,Chen Q,et al. Endothelial shear stress signal transduction and atherogenesis:from mechanisms to therapeutics[J]. Pharmacol Ther,2022,235:108152.
[7] Fernández-Vizarra E,Callegari S,Garrabou G,et al. Editorial:mitochondrial OXPHOS system:emerging concepts and technologies and role in disease[J]. Front Cell Dev Biol,2022,10:924272.
[8] Xu S,Ilyas I,Little PJ,et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond:from mechanism to pharmacotherapies[J]. Pharmacol Rev,2021,73 (3):924-967.
[9] Lurette O,Guedouari H,Morris JL,et al. Mitochondrial matrix-localized Src kinase regulates mitochondrial morphology[J]. Cell Mol Life Sci,2022,79 (2):327.
[10] Tian X,Huang Y,Zhang X,et al. Salidroside attenuates myocardial ischemia/reperfusion injury via AMPK-induced suppression of endoplasmic reticulum stress and mitochondrial fission[J]. Toxicol Appl Pharmacol,2022,448:116093.
[11] Liu Y,Wang S,Zhang X,et al. The regulation and characterization of mitochondrial-derived methylmalonic acid in mitochondrial dysfunction and oxidative stress:from basic research to clinical practice[J]. Oxid Med Cell Longev,2022,2022:7043883.
[12] He L,Li Y,Zhang D,et al. Dapagliflozin improves endothelial cell dysfunction by regulating mitochondrial production via the SIRT1/PGC-1α pathway in obese mice[J]. Biochem Biophys Res Commun,2022,615:123-130.
[13] Tracy EP,Hughes W,Beare JE,et al. Aging-induced impairment of vascular function:mitochondrial redox contributions and physiological/clinical implications[J]. Antioxid Redox Signal,2021,35 (12):974-1015.
[14] Farshori NN,Saquib Q,Siddiqui MA,et al. Protective effects of Nigella sativa extract against H2O2-induced cell death through the inhibition of DNA damage and cell cycle arrest in human umbilical vein endothelial cells(HUVECs)[J]. J Appl Toxicol,2021,41 (5):820-831.
[15] Wang H,Sugimoto K,Lu H,et al. HDAC1-mediated deacetylation of HIF1α prevents atherosclerosis progression by promoting miR-224-3P-mediated inhibition of FOSL2[J]. Mol Ther Nucleic Acids,2021,23:577-591.
[16] Li X,Li R,You N,et al. Butyric acid ameliorates myocardial fibrosis by regulating M1/M2 polarization of macrophages and promoting recovery of mitochondrial function[J]. Front Nutr,2022,9:875473.
[17] Wang Y,Subramanian M,Yurdagul A J r,et al. Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages[J]. Cell,2017,171 (2):331-345.e22.
[18] Karunakaran D,Thrush AB,Nguyen MA,et al. Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis[J]. Circ Res,2015,117 (3):266-278.
[19] Tyrrell DJ,Blin MG,Song J,et al. Age-associated mitochondrial dysfunction accelerates atherogenesis[J]. Circ Res,2020,126 (3):298-314.
[20] Huynh DTN,Heo KS. Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis[J]. Arch Pharm Res,2021,44 (12):1051-1061.
[21] Chen NX,O’Neill KD,Dominguez JM 2nd,et al. Regulation of reactive oxygen species in the pathogenesis of matrix vesicles induced calcification of recipient vascular smooth muscle cells[J]. Vasc Med,2021,26 (6):585-594.
[22] Wei Y,Corbalán-Campos J,Gurung R,et al. Dicer in macrophages prevents atherosclerosis by promoting mitochondrial oxidative metabolism[J]. Circulation,2018,138 (18):2007-2020.
[23] Rodríguez C,Mu?oz M,Contreras C,et al. AMPK,metabolism,and vascular function[J]. FEBS J,2021,288 (12):3746-3771.
[24] Silva J,Spatz MH,Folk C,et al. Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK/Sirt-1/PGC-1α signaling axis[J]. Alcohol,2021,91:1-9.
[25] Das S,Chattopadhyay D,Chatterjee SK,et al. Increase in PPARγ inhibitory phosphorylation by Fetuin-A through the activation of Ras-MEK-ERK pathway causes insulin resistance[J]. Biochim Biophys Acta Mol Basis Dis,2021,1867 (4):166050.
[26] Amirazodi M,Mehrabi A,Rajizadeh MA,et al. The effects of combined resveratrol and high intensity interval training on the hippocampus in aged male rats:an investigation into some signaling pathways related to mitochondria[J]. Iran J Basic Med Sci,2022,25 (2):254-262.
[27] Montecino-Garrido H,Méndez D,Araya-Maturana R,et al. In vitro effect of mitochondria-targeted triphenylphosphonium-based compounds(honokiol,lonidamine,and atovaquone) on the platelet function and cytotoxic activity[J] . Front Pharmacol,2022,13:893873 .
[28] 陈航,胡琴丰,林丽,等. 线粒体移植在心肌缺血损伤治疗中的研究[J]. 自然杂志,2022,44(2):109-116.
[29] Zhou M,Yu Y,Luo Y,et al. Mitochondrial transplantation:a unique treatment strategy[J]. J Cardiovasc Pharmacol,2022,79 (6):759-768.
[30] Bravo-San Pedro JM,Kroemer G,Galluzzi L. Autophagy and mitophagy in cardiovascular disease[J]. Circ Res,2017,120 (11):1812-1824.
[31] Broome SC,Pham T,Braakhuis AJ,et al. MitoQ supplementation augments acute exercise-induced increases in muscle PGC1α mRNA and improves training-induced increases in peak power independent of mitochondrial content and function in untrained middle-aged men[J]. Redox Biol,2022,53:102341.
相似文献/References:
[1]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(11):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[2]耿春晖 关秀茹.MicroRNA作为动脉粥样硬化的诊断生物标志物的研究进展[J].心血管病学进展,2019,(7):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
GENG Chunhui,GUAN Xiuru.microRNA as a Diagnostic Biomarker for Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(11):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
[3]乐健 何胜虎.前蛋白转化酶枯草溶菌素9致动脉粥样硬化的机制研究进展[J].心血管病学进展,2019,(7):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
YUE Jian,HE Shenghu.Advances in the mechanism of PCSK9-induced atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(11):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
[4]武亚琳,梁斌,杨志明.NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J].心血管病学进展,2019,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
WU Yalin,LIANG Bin,YANG Zhiming.The Role of NLRP3/IL-1in Atherosclerosis and Clinical Application[J].Advances in Cardiovascular Diseases,2019,(11):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
[5]李琦玉 ?张宁 陈婧 黄浙勇.动脉粥样硬化的抗血小板分子靶向治疗[J].心血管病学进展,2019,(5):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
LI Qiyu,ZHANG Ning,CHEN Jing,et al.Anti-Platelet Molecular Targeted Therapy or Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(11):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
[6]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(11):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[7]焦新峰 刘正霞 鲁翔.白介素-8在冠心病中的研究进展[J].心血管病学进展,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
JIAO Xinfeng,LIU Zhengxia,LU Xiang.Research Progress of Interleukin-8 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(11):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
[8]徐侨 刘正霞 鲁翔.白介素22在动脉粥样硬化和2型糖尿病中的作用[J].心血管病学进展,2019,(9):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
XU Qiao,LIU Zhengxia,LU Xiang.IL-22 in Atherosclerosis and Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(11):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
[9]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(11):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[10]代承忠 彭礼清 余建群 刘静 蒲华霞.双源CT血管成像评价经导管主动脉瓣置入术术前患者颈动脉斑块[J].心血管病学进展,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]
DAI Chengzhong,PENG Liqing,YU Jianqun,et al.Evaluation of Carotid Arteries Plaques in Patients Referred for TAVI with Dual-source CT Angiography[J].Advances in Cardiovascular Diseases,2019,(11):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]